28.34 USD
↘ 0.96 (3.26%)LIVE (AS OF 03:00 PM EDT)
Roivant Sciences Ltd. Common Shares
ROIVNASDAQ • USD
Market: OPEN
Open?$29.30
High?$30.21
Low?$28.25
Prev. Close?$29.29
Volume?2.3M
Avg. Volume?4.9M
VWAP?$28.55
Rel. Volume?0.47x
Bid / Ask
Bid?$28.32 × 600
Ask?$28.33 × 300
Spread?$0.01
Midpoint?$28.33
Valuation & Ratios
Market Cap?21.0B
Shares Out?715.7M
Float?371.0M
Float %?51.8%
P/E Ratio?N/A
P/B Ratio?4.91
EPS?-$1.13
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
Employees
750
Market Cap
21.0B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-10-01
Address
7TH FLOOR, 50 BROADWAY
LONDON, SW1H 0DB
Phone: 441-295-5950
LONDON, SW1H 0DB
Phone: 441-295-5950
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?30.66Strong
Quick Ratio?30.66Strong
Cash Ratio?9.73Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score58/100
P/E?N/A▾
P/B?4.91FAIR▾
P/S?1,574.97HIGH▾
P/FCF?N/A▾
EV/EBITDA?-16.1CHEAP▾
EV/Sales?1,463.91HIGH▾
Returns & Efficiency
ROE?-19.0%WEAK▾
ROA?-15.5%WEAK▾
Cash Flow & Enterprise
FCF?$-766855000
Enterprise Value?$19.5B
Fundamentals ratios updated end of day